Mednet Logo

How do you determine your treatment volumes when treating with chemoradiation for bladder cancer?

Do you routinely include pelvic lymph nodes, prostatic urethra, and prostate?
Community PollStarted

What are your fields when treating bladder cancer with chemoradiation?

257 physicians have voted

Join Mednetto vote and see how they answered.

5 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Harvard Medical School
Answered on

Good question! The fields for bladder preservation with chemoradiation have not been standardized, and there are multiple reasonable options based on trials/experiences for certain fields. In general, it is important to try to minimize dose of RT to adjacent tissues that are more sensitive. Because ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Wellspan Sechler Family Cancer Center
Answered on

I have found that I can do a partial bladder boost most effectively by starting with the boost, when it is easiest for patients to maintain full bladder.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · UC San Diego
Answered on

It is a great and difficult question, as evidenced by the SWOG trial @Dr. First Last referenced.

Perhaps the strongest evidence for concurrent chemotherapy comes from BC2001 (James et al. NEJM 2012), which showed a DFS benefit (and trend for OS). The protocol for that study describes 3D conformal te...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Pittsburgh
Answered on

In my opinion, the most troubling organ in this situation is the small bowel. To my knowledge, there is no data on small bowel dose, nor have I ever seen it addressed in any bladder protocol. Yet, treating the bladder to full dose (either 55 Gy in 20 or conventional 64 Gy) would eclipse what we trad...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Lynn Cancer Institute at Boca Raton Regional Hospital
Answered on

We believe that being able to reduce off some of the bladder reduces toxicity, although acknowledge that data are lacking. Knowing where to boost (identifying the reduction target) is often a challenge and we discuss each case and review films with our urologists. We have discussed placing markers o...

Join for free or sign in to see the full answer